Skip to content

Benefit of CFAE Ablation

A Study to Investigate the Benefit Of Complex Fractionated Atrial Electrogram (CFAE) Ablation in Addition to Circumferential Pulmonary Vein and Linear Ablations in the Treatment of Persistent Atrial Fibrillation. (BOCA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01711047
Acronym
BOCA
Enrollment
120
Registered
2012-10-22
Start date
2010-03-31
Completion date
2013-08-31
Last updated
2017-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation

Keywords

catheter ablation, atrial fibrillation, pulmonary vein isolation, linear ablation, CFAE ablation

Brief summary

The optimal strategy for catheter ablation of persistent atrial fibrillation is not clearly defined. This study investigates if Complex Fractionated Atrial Electrogram (CFAE) ablation in addition to pulmonary vein isolation and linear ablations improves single procedural success rate over a 12 month follow up period.

Interventions

PROCEDURERadiofrequency catheter Ablation

In this arm, catheter ablation would be performed in the left atrium and would include pulmonary vein isolation and linear ablations (roof and mitral isthmus lines)

PROCEDURERadiofrequency catheter ablation

In this arm, catheter ablation would be performed in the left atrium, including pulmonary vein isolation, linear ablations (roof and mitral isthmus lines) and Complex Fractionated Atrial Electrograms (CFAE) ablation.

Sponsors

Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
CollaboratorOTHER_GOV
Oxford University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* persistent atrial fibrillation

Exclusion criteria

* previous catheter or surgical ablation for atrial fibrillation * pregnancy

Design outcomes

Primary

MeasureTime frame
Single procedural success rate (free from AF off anti-arrhythmic drugs)12 MONTHS

Secondary

MeasureTime frameDescription
Ablation timeTime 0This information will be recorded immediately after the procedure.
Procedure timeTime 0This information will be recorded immediately after the procedure
recurrence of atrial fibrillation or organised atrial tachycardia12 months after the last procedure
Complication rate30 days of procedure
Percentage of AF terminationTime 0This information will be recorded immediately after the procedure.
Multiple procedure success rate12 months after last ablation

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026